Diabetic dyslipidaemia – clinical importance and treatment

Anna Rubiec-Niemirowska; Anna Czech

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

2/2009
vol. 12

Send email

Copy url:

abstract:

Diabetic dyslipidaemia – clinical importance and treatment

Anna Rubiec-Niemirowska

,

Anna Czech

Przew Lek 2009; 2: 61-67

Online publish date: 2009/07/21

View full text Get citation

In diabetes type 2 atherogenic dyslipidaemia is 2-3 times more frequent than in the general population. Atherogenic dyslipidaemia includes: high level of triglycerides and LDL cholesterol, low level of HDL cholesterol. Early diagnosis and treatment of dyslipidaemia play an important role in protection against cardiovascular diseases. Treatment is combined with non-pharmacological and pharmacological methods. Non-pharmacological treatment includes diet and physical activity. In pharmacological treatment the main role is played by statins, which decrease LDL cholesterol. A second important group is fibrates, which decrease triglycerides and increase HDL cholesterol.

keywords:

Diabetic dyslipidaemia – clinical importance and treatment

Anna Rubiec-Niemirowska , Anna Czech

diabetes type 2, atherogenic dyslipidaemia, statin, fibrates

Anna Rubiec-Niemirowska

,

Anna Czech